Literature DB >> 27934660

EZH2 deletion in early mesenchyme compromises postnatal bone microarchitecture and structural integrity and accelerates remodeling.

Sarah Hemming1,2, Dimitrios Cakouros1,2, John Codrington3, Kate Vandyke2,4,5, Agneiszka Arthur1,2, Andrew Zannettino2,4, Stan Gronthos6,2.   

Abstract

In this study, we examined the functional importance of EZH2 during skeletal development and homeostasis using the conditional deletion of Ezh2 (Ezh2fl/fl ) in early mesenchyme with the use of a Prrx-1-cre driver mouse (Ezh2+/+). Heterozygous (Ezh2+/-) newborn and 4-wk-old mice exhibited increased skeletal size, growth plate size, and weight when compared to the wild-type control (Ezh2+/+), whereas homozygous deletion of Ezh2 (Ezh2-/-) resulted in skeletal deformities and reduced skeletal size, growth plate size, and weight in newborn and 4-wk-old mice. Ezh2-/- mice exhibited enhanced trabecular patterning. Osteogenic cortical and trabecular bone formation was enhanced in Ezh2+/- and Ezh2-/- animals. Ezh2+/- and Ezh2-/- mice displayed thinner cortical bone and decreased mechanical strength compared to the wild-type control. Differences in cortical bone thickness were attributed to an increased number of osteoclasts, corresponding with elevated levels of the bone turnover markers cross-linked C-telopeptide-1 and tartrate-resistant acid phosphatase, detected within serum. Moreover, Ezh2+/- mice displayed increased osteoclastogenic potential coinciding with an upregulation of Rankl and M-csf expression by mesenchymal stem cells (MSCs). MSCs isolated from Ezh2+/- mice also exhibited increased trilineage potential compared with wild-type bone marrow stromal/stem cells (BMSCs). Gene expression studies confirmed the upregulation of known Ezh2 target genes in Ezh2-/- bone tissue, many of which are involved in Wnt/BMP signaling as promoters of osteogenesis and inhibitors of adipogenesis. In summary, EZH2 appears to be an important orchestrator of skeletal development, postnatal bone remodelling and BMSC fate determination in vitro and in vivo-Hemming, S., Cakouros, D., Codrington, J., Vandyke, K., Arthur, A., Zannettino, A., Gronthos, S. EZH2 deletion in early mesenchyme compromises postnatal bone microarchitecture and structural integrity and accelerates remodeling. © FASEB.

Entities:  

Keywords:  conditional knockout; differentiation; epigenetics; mesenchymal stem cells; skeletal development

Mesh:

Substances:

Year:  2016        PMID: 27934660     DOI: 10.1096/fj.201600748R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  25 in total

Review 1.  Epigenetics as a New Frontier in Orthopedic Regenerative Medicine and Oncology.

Authors:  Andre J van Wijnen; Jennifer J Westendorf
Journal:  J Orthop Res       Date:  2019-04-25       Impact factor: 3.494

2.  The histone methyltransferase EZH2 is required for normal uterine development and function in mice†.

Authors:  Manjunatha K Nanjappa; Ana M Mesa; Theresa I Medrano; Wendy N Jefferson; Francesco J DeMayo; Carmen J Williams; John P Lydon; Ellis R Levin; Paul S Cooke
Journal:  Biol Reprod       Date:  2019-08-01       Impact factor: 4.285

3.  Loss of histone methyltransferase Ezh2 stimulates an osteogenic transcriptional program in chondrocytes but does not affect cartilage development.

Authors:  Emily T Camilleri; Amel Dudakovic; Scott M Riester; Catalina Galeano-Garces; Christopher R Paradise; Elizabeth W Bradley; Meghan E McGee-Lawrence; Hee-Jeong Im; Marcel Karperien; Aaron J Krych; Jennifer J Westendorf; A Noelle Larson; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

4.  FGFR2 accommodates osteogenic cell fate determination in human mesenchymal stem cells.

Authors:  Ying Zhang; Ling Ling; Arya Ajay D/O Ajayakumar; Yating Michelle Eio; Andre J van Wijnen; Victor Nurcombe; Simon M Cool
Journal:  Gene       Date:  2022-01-29       Impact factor: 3.913

5.  Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2.

Authors:  Amel Dudakovic; Rebekah M Samsonraj; Christopher R Paradise; Catalina Galeano-Garces; Merel O Mol; Daniela Galeano-Garces; Pengfei Zan; M Lizeth Galvan; Mario Hevesi; Oksana Pichurin; Roman Thaler; Dana L Begun; Peter Kloen; Marcel Karperien; A Noelle Larson; Jennifer J Westendorf; Simon M Cool; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2020-04-24       Impact factor: 5.157

6.  Enhancer of zeste homolog 2 (Ezh2) controls bone formation and cell cycle progression during osteogenesis in mice.

Authors:  Amel Dudakovic; Emily T Camilleri; Christopher R Paradise; Rebekah M Samsonraj; Martina Gluscevic; Carlo Alberto Paggi; Dana L Begun; Farzaneh Khani; Oksana Pichurin; Farah S Ahmed; Ranya Elsayed; Mohammed Elsalanty; Meghan E McGee-Lawrence; Marcel Karperien; Scott M Riester; Roman Thaler; Jennifer J Westendorf; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2018-06-13       Impact factor: 5.157

7.  EZH2 Supports Osteoclast Differentiation and Bone Resorption Via Epigenetic and Cytoplasmic Targets.

Authors:  Juraj Adamik; Sree H Pulugulla; Peng Zhang; Quanhong Sun; Konstantinos Lontos; David A Macar; Philip E Auron; Deborah L Galson
Journal:  J Bone Miner Res       Date:  2019-10-23       Impact factor: 6.741

8.  Multiple pharmacological inhibitors targeting the epigenetic suppressor enhancer of zeste homolog 2 (Ezh2) accelerate osteoblast differentiation.

Authors:  M Lizeth Galvan; Christopher R Paradise; Eva Kubrova; Sofia Jerez; Farzaneh Khani; Roman Thaler; Amel Dudakovic; Andre J van Wijnen
Journal:  Bone       Date:  2021-04-30       Impact factor: 4.626

9.  Ezh2 Is Essential for Patterning of Multiple Musculoskeletal Tissues but Dispensable for Tendon Differentiation.

Authors:  Deepanwita Pal; Scott M Riester; Bashar Hasan; Sara F Tufa; Amel Dudakovic; Douglas R Keene; Andre J van Wijnen; Ronen Schweitzer
Journal:  Stem Cells Dev       Date:  2021-04-27       Impact factor: 4.390

10.  Fatty acids derived from apoptotic chondrocytes fuel macrophages FAO through MSR1 for facilitating BMSCs osteogenic differentiation.

Authors:  Zi-Yang Zheng; Tao Jiang; Zhen-Fei Huang; Bo Chu; Jun Gu; Xuan Zhao; Hao Liu; Jin Fan; Li-Peng Yu; Shu-Heng Jiang; Qing Li; Li-Peng Hu; Fan-Qi Kong; Lai Zhang; Qi Chen; Jian Chen; Han-Wen Zhang; Guo-Yong Yin; Shu-Jie Zhao
Journal:  Redox Biol       Date:  2022-04-30       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.